For a long time, high-density lipoprotein cholesterol (HDL-C) has been regarded as a
cardiovascular disease (CVD) protective factor. Recently, several epidemiological studies …

Cardiac arrhythmias are associated with substantial morbidity and mortality. Recent
advances in the pathophysiological understanding of cardiac arrhythmia indicate that …

Background Non-alcoholic fatty liver disease (NAFLD) is a common liver disease increasing
cardiovascular disease (CVD) morbidity and mortality. Autoantibodies against …

Background SARS‐CoV‐2 infection triggers different auto‐antibodies, including anti‐
apolipoprotein A‐1 IgGs (AAA1), which could be of concern as mediators of persistent …

Functional assessment of cholesterol efflux capacity (CEC) to high-density lipoprotein (HDL)
is an emerging tool for evaluating morbidity and mortality associated with cardiovascular …

Background Unravelling autoimmune targets triggered by SARS‐CoV‐2 infection may
provide crucial insights into the physiopathology of the disease and foster the development …

Introduction The new coronavirus disease, COVID-19, poses complex challenges
exacerbated by several factors, with respiratory tissue lesions being notably significant …

Objective To validate the prognostic accuracy of anti-apolipoprotein A-1 (AAA1) IgG for
incident major adverse cardiovascular (CV) events (MACE) in rheumatoid arthritis (RA) and …

Background: Neutrophils accumulate in atherosclerotic plaques. Neutrophil extracellular
traps (NET) were recently identified in experimental atherosclerosis and in complex human …

Aims: Anti-Apolipoprotein A-1 autoantibodies (anti-ApoA-1 IgG) promote atherogenesis via
innate immune receptors, and may impair cellular cholesterol homeostasis (CH). We …